This webinar, hosted by Jen and sponsored by Roos, features Dr. Jim Huggett and Ban Gan discussing the fundamental differences, applications, advantages, and limitations of digital PCR (dpcr) and quantitative real-time PCR (qpcr). The discussion highlights dpcr's superior precision, sensitivity, and true absolute quantification through sample partitioning and endpoint analysis, making it ideal for tasks like copy number variation, rare mutation detection, and analysis in the presence of inhibitors. In contrast, qpcr offers higher throughput, broader dynamic range, and established automation, proving indispensable for high-volume applications like pandemic diagnostics. While dpcr instrumentation requires additional partitioning steps and is currently more expensive, its robust reproducibility and absolute quantification capabilities are transformative for metrology and inter-laboratory comparability, often negating the need for extensive calibration. Both technologies are deemed complementary, with ongoing innovations like advanced multiplexing and novel linkage assays further expanding their utility in molecular analysis.
Summarizing dpcr vs. qpcr: Selecting the Right Tool for Molecular Analysis
0:00 Introduction to dpcr vs. qpcr: The webinar, hosted by Jen and sponsored by Roos, introduces the topic of selecting between digital PCR (dpcr) and quantitative real-time PCR (qpcr) for molecular analysis, highlighting their distinct approaches and applications.
0:22 Fundamental Differences: Jim Huggett explains qpcr measures real-time fluorescence increase in a bulk reaction to quantify DNA, while dpcr partitions the sample into thousands of tiny reactions. dpcr then counts positive partitions at the endpoint, offering "true absolute quantification" without needing a standard curve (Ban Gan at 0:06:00).
0:11:10 Instrumentation Differences: Ban Gan notes dpcr requires an upfront instrument for partitioning, followed by a thermal cycler and analyzer. Jim Huggett adds that this creates an additional step compared to qpcr's automated "set up and forget" workflow.
0:07:00 Lab Setup Implications: It's crucial to separate pre- and post-PCR areas in the lab for both technologies to prevent contamination, especially for dpcr which is highly sensitive to single molecules. Modern dpcr instruments are integrating steps, but some still require distinct partitioning and analysis phases.
0:11:09 Quantification Methods: qpcr uses an analog amplification curve and a cycle threshold (CT value) for quantification, which Jim highlights as highly variable (hundreds of fold difference possible between labs/assays) and reliant on calibration. dpcr, being "digital," counts positive vs. negative partitions (1s and 0s), offering absolute quantification and reducing variability without standards.
0:14:48 Limitations of dpcr: Jim Huggett emphasizes qpcr's strengths, including its massive dynamic range (dpcr typically 100,000 partitions max), established widespread use, and cost-effectiveness. He credits qpcr reagent development for enabling dpcr's success.
0:17:01 Complementary Technologies: Both speakers agree that dpcr and qpcr are complementary, not competing. qpcr excels in high-throughput and cost-efficiency, while dpcr provides higher precision, sensitivity, and absolute quantification.
0:18:18 Applications for dpcr: dpcr performs better in applications requiring high resolution and sensitivity, such as copy number variation (CNV) assays, rare mutation detection (e.g., minimal residual disease at 1% allele frequency or less), and samples with PCR inhibitors (due to dilution effect).
0:21:52 Precision and Reproducibility: Jim explains dpcr's precision is dictated by the statistical distribution of molecules, making it inherently more reproducible. It can measure incredibly small differences (e.g., 1.05-fold changes) that pipetting errors often mask. This high reproducibility (agreement within two-fold across labs globally) is a "game-changer" for metrology and comparing absolute measurements.
0:28:50 Data Analysis Differences: qpcr analysis relies on software algorithms to determine CT values from amplification curves, while dpcr involves distinguishing positive from negative endpoint fluorescence signals, which can be challenging with multiplexing or gray areas.
0:32:20 Multiplexing Capabilities: Both technologies can multiplex. qpcr multiplexing is challenging to optimize for quantification, but dpcr multiplexing is simpler, akin to flow cytometry, allowing for multiple targets per color through probe concentration differences. Modern dpcr can achieve up to 6-7 channels.
0:34:57 Cost Differences: Ban Gan states dpcr is currently more expensive than qpcr due to its novelty and lower throughput (qpcr can run 384 samples on a single plate). However, dpcr's reliable results and reduced need for extensive calibration can lead to overall cost savings.
0:37:00 dpcr Linkage Assays: Jim describes an innovation called "drop-off assays" in dpcr that allow measuring the presence of "unseen" scrambled sequences, such as in CRISPR analysis, by detecting linked molecules with other probes.
0:39:02 Increased Partitioning: Ban highlights Roos's Digital LightCycler, offering 20,000 to 100,000 partitions for increased confidence and improved nanowell technology to prevent amplicon contamination.
0:39:50 Enhanced qpcr: Roos also launched the LightCycler Pro with enhanced temperature uniformity, improved software, and a seven-channel optical capability, supporting both research and IVD applications.
0:41:02 Q&A Session: The webinar concludes, transitioning to a live Q&A session.